Vetgrad logo
VetGrad Ask An Expert Sign in Register for FREE Forum Competition VetGrad Offers Contact Us
Search
Powered by Google
Home

Home

10 Minute Top Up

CPD

Resources

How To

YVN

Need to Know

Jobs

Oops

PDP/PDR

Why Bother?


Ask An Expert

Sign in

Register for FREE

Forum

Competition

VetGrad Offers

Contact Us

 Tackling antiobiotic resistance is imperative say veterinary medicine industry body

HealthforAnimals welcomed initiatives to table the issue of antibiotic resistance at the 41st G7 Summit in Upper Bavaria on 7 and 8 June 2015. The association believes it is important that antibiotics, are used responsibly whenever they are employed, whether by the human medical world, the veterinary sector, or elsewhere.

Antibiotics are a vital part of the veterinarian’s toolkit. They are necessary to fight bacterial infections in animals, farming animals and pets alike. From a welfare and ethical point of view, it is necessary to preserve these antibiotics: inflammatory conditions like mastitis and lameness are extremely painful for the animal concerned and farmers have a moral duty to avoid suffering.

HealthforAnimals encourages a stronger dialogue and co-operation between the two medical sectors to ensure the continued availability of antibiotics for both human and veterinary medicines. Another factor to push forward is the increased need for innovation within both sectors to find new antibiotics.

Carel du Marchie Sarvaas, HealthforAnimals’ Executive Director said, “As an industry sector we actively promote the responsible use of all our products, including antibiotics, and we engage with several platforms on this topic”.

“Effective and targeted use of antibiotics will be an essential part of any strategy to turn back the tide of infectious disease and increased resistance. In addition to all stakeholders involved adopting measures to ensure appropriate and responsible use, there is also a need for a regulatory environment which stimulates innovation and allows the global animal health industry - as well as the human pharmaceutical sector - to keep developing new and innovative products.”

“There is a need to agree on successful strategies to keep existing antibiotics working to the benefit of all, and we can only achieve that through cross-cooperation between the two medical sectors together with all stakeholders involved.”

Follow us:
Share this page: